Calliditas Drug Patent Portfolio
Calliditas owns 1 orange book drug protected by 5 US patents Given below is the list of Calliditas's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11896719 | Pharmaceutical compositions | 23 Jan, 2043 | Active |
| US12171882 | Pharmaceutical compositions | 23 Jan, 2043 | Active |
| US12171883 | Pharmaceutical compositions | 23 Jan, 2043 | Active |
| US12311057 | Pharmaceutical compositions | 23 Jan, 2043 | Active |
| US8491932 | Compositions for the oral delivery of corticosteroids | 07 May, 2029 | Active |
Latest Legal Activities on Calliditas's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Calliditas.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 03 Jun, 2025 | US12311057 |
| Email Notification | 27 May, 2025 | US12311057 |
| Patent eGrant Notification | 27 May, 2025 | US12311057 |
| Mail Patent eGrant Notification | 27 May, 2025 | US12311057 |
| Patent Issue Date Used in PTA Calculation | 27 May, 2025 | US12311057 |
| Recordation of Patent eGrant | 27 May, 2025 | US12311057 |
| Email Notification | 15 May, 2025 | US12311057 |
| Issue Notification Mailed | 14 May, 2025 | US12311057 |
| Application Is Considered Ready for Issue | 06 May, 2025 | US12311057 |
| Dispatch to FDC | 06 May, 2025 | US12311057 |
| Issue Fee Payment Received | 29 Apr, 2025 | US12311057 |
| Issue Fee Payment Verified | 29 Apr, 2025 | US12311057 |
| Mail Notice of Allowance | 24 Apr, 2025 | US12311057 |
| Notice of Allowance Data Verification Completed | 22 Apr, 2025 | US12311057 |
| Information Disclosure Statement considered | 17 Apr, 2025 | US12311057 |
Calliditas Drug Patents' Oppositions Filed in EPO
Calliditas drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Oct 01, 2014, by Dr. Falk Pharma Gmbh. This opposition was filed on patent number EP09746033A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP09746033A | Oct, 2014 | Dr. Falk Pharma GmbH | Opposition rejected |
Calliditas's Family Patents
Calliditas Drug List
Given below is the complete list of Calliditas's drugs and the patents protecting them.
1. Tarpeyo
Tarpeyo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11896719 | Pharmaceutical compositions |
23 Jan, 2043
(16 years from now)
| Active |
| US12171882 | Pharmaceutical compositions |
23 Jan, 2043
(16 years from now)
| Active |
| US12171883 | Pharmaceutical compositions |
23 Jan, 2043
(16 years from now)
| Active |
| US12311057 | Pharmaceutical compositions |
23 Jan, 2043
(16 years from now)
| Active |
| US8491932 | Compositions for the oral delivery of corticosteroids |
07 May, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tarpeyo's drug page